Clover Health Guides to Profitability with $50–$70M EBITDA, 38% Membership Growth
Clover Health's Medicare Advantage enrollment rose 38% year-over-year to 113,803 members in Q4 2025, supporting durable revenue expansion. The company expects 2026 adjusted EBITDA of $50–$70 million and GAAP profit up to $20 million while addressing a 90.9% insurance benefit expense ratio and regulatory spending cuts.
1. Membership Growth and Star Rating
Clover closed Q4 2025 with 113,803 Medicare Advantage members, a 38% year-over-year increase, and secured a 4-Star CMS rating for its flagship PPO plan, enhancing quality bonus payments and plan economics.
2. Profitability Guidance
Management forecasts GAAP net income between breakeven and $20 million and adjusted EBITDA of $50–$70 million for 2026, driven by 4-Star payment year benefits, favorable Part C rates, and expanded technology engagement.
3. Cost Pressures and Expense Ratio
Clover reported a 90.9% Insurance Benefit Expense Ratio in 2025, up 970 basis points, reflecting elevated member utilization, near-term margin pressure from a Clover Assistant rollout, and higher inpatient costs.
4. Regulatory Environment and Policy Risks
The company faces potential headwinds from automatic 4% Medicare spending cuts under the new federal bill, risk adjustment changes and policy shifts that could affect reimbursement levels and enrollment dynamics.